George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSomero Regulatory News (SOM)

Share Price Information for Somero (SOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 335.00
Bid: 330.00
Ask: 340.00
Change: -3.00 (-0.90%)
Spread: 10.00 (3.03%)
Open: 335.00
High: 332.00
Low: 332.00
Prev. Close: 335.00
SOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

20 Jun 2023 07:00

RNS Number : 2241D
Somero Enterprises Inc.
20 June 2023
 

20 June 2023

Somero Enterprises, Inc.

("Somero" or "the Company")

 

Trading Update

 

Somero Enterprises, Inc. provides the following update on trading for the five months ended 31 May 2023 and on expectations for 2023 results. 

 

The US non-residential construction market has remained active, supported by customers reporting extended project backlogs across a wide range of sectors and project types including large manufacturing facilities, data centres and medical facilities. Alongside this, the positive momentum in Europe and Australia has carried over from 2022 into 2023. The health of non-residential construction activity in the US, Europe and Australia, the Company's three main markets, that formed the basis for the 2023 outlook provided in the Company's Final Results statement on 8 March 2023, has remained intact. 

 

While underlying market conditions remain positive, new factors have emerged to impact the translation of construction activity into trading in the US. Elevated interest rates, tightened bank lending standards and, to a lesser degree, construction permitting delays due to large complex projects creating bottlenecks in the approval process in certain portions of the US, have led to an increase in delayed starts to non-residential construction projects. While US customers have not reported project cancellations, certain customers have indicated these project delays have impacted the timing of their equipment purchase decisions. In addition, the S-22EZ, re-launched in early 2023, is not scheduled to reach full production until the end of H1 2023, and its limited availability has delayed sales to customers with a preference for it. Other market factors noted in the Final Results statement, most notably a limited supply of concrete across the US, have remained unchanged. 

 

Having considered these current factors, the Company expects H1 2023 revenue will range between 15% and 20% below the record US$ 68.5m revenue reported in H1 2022. The Company now expects 2023 revenue will approximate US$ 120.0m, approximately 10% below 2022 revenue of US$ 133.6m. The Company anticipates an improvement in H2 2023 revenues over H1 2023 driven primarily by increased availability of the S-22EZ during the second half of the year. Lowered expectations for H1 2023 and FY 2023 revenue have been driven primarily by the US market. We continue to anticipate strong contributions to 2023 revenue from Europe, Australia, and the Rest of World territories, with Europe and Australia each expected to report H1 2023 revenue that meets or exceeds the comparable H1 2022 total. 

 

Somero's operating model enables it to adjust quickly to changing circumstances. Due to the anticipated 10% reduction in 2023 sales compared to previous expectations, the Company has reduced its operational workforce by 10%, a restructuring that takes effect alongside this trading update. The workforce reduction combined with strict cost controls for the remainder of 2023 partly offset the profitability impact of the revised 2023 revenue expectations. The Company has also taken additional steps to minimize inventory levels. These measures include frequent reviews of safety stock levels to ensure carrying amounts are optimal, and aggressively adjusting inbound inventory purchasing to align with anticipated volume. The impact of these efforts along with maintaining accounts receivable at low levels are anticipated to have a positive impact on year-end cash.

 

In consideration of the aforementioned factors, the Company now expects FY 2023 revenues of approximately US$ 120.0m (compared to the previous market consensus estimate of US$ 132.1m), EBITDA of approximately US$ 36.0m (compared to the previous market consensus estimate of US$ 42.8m), and year-end cash of approximately US$ 32.0m (compared to the previous market consensus estimate of US$ 31.0m). The improvement in 2023 year-end cash compared to the market estimate is attributable to expectations for a meaningfully lower level of net working capital investment in 2023 due to the drivers previously noted.

 

Jack Cooney, CEO of Somero, said:

 

"Our customers continue to report high levels of non-residential construction activity across our territories. While some projects in the US are experiencing delays, we are confident the underlying market remains in good health and provides the Company meaningful opportunity. We expect to see an improved second-half with strong demand for the S-22EZ that will reach full production imminently.

 

Outside the US, we are pleased with the performance in Europe and Australia that are each poised to deliver strong first half and full year contributions.

 

Our proven operating model provides the Company the flexibility, through a high level of variable costs, to adapt quickly and effectively to changing conditions. This continues to be a key strength of the Company. As such, we have been able to mitigate the impact of reduced near-term volumes on profitability without compromising our long-term growth initiatives."

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 as retained as part of UK law by virtue of the European Union (Withdrawal) Act 2018 as amended. Upon the publication of this Announcement, this inside information is now considered to be in the public domain.

Enquiries:

 

 

 

 

Somero Enterprises, Inc.

Jack Cooney, CEO

John Yuncza, President

Vincenzo LiCausi, CFO

Howard Hohmann, EVP Sales

 

www.somero.com

+1 239 210 6500

 

 

 

finnCap Ltd (NOMAD and Broker)

Matt Goode/Seamus Fricker/Fergus Sullivan (Corporate Finance)Tim Redfern/Harriet Ward (ECM)

+44 (0)20 7220 0500

 

 

Alma PR (Financial PR Advisor)

David Ison

Pippa Crabtree

somero@almapr.co.uk

+44 (0)20 3405 0205

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTNKCBKDBKBBAD
Date   Source Headline
24th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
5th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Mar 20246:06 pmRNSTransaction in Own Shares and Total Voting Rights
19th Mar 20243:07 pmRNSRestricted Stock Units& Director/PDMR Shareholding
5th Mar 20247:00 amRNSFinal Results
7th Feb 20247:00 amRNSNotice of Investor Presentation
31st Jan 20247:00 amRNSTrading Update
5th Jan 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Jan 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
13th Dec 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Dec 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Dec 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Nov 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Nov 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Oct 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Oct 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Oct 20237:55 amRNSTransaction in Own Shares and Total Voting Rights
2nd Oct 20237:00 amRNSBoard Change
27th Sep 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Sep 20238:49 amRNSTransaction in Own Shares and Total Voting Rights
18th Sep 20237:00 amRNSDirector/PDMR Shareholding & Change of NOMAD name
13th Sep 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
31st Aug 20237:00 amRNSInterim Results
29th Aug 20237:00 amRNSBoard Change
8th Aug 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Aug 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
31st Jul 20237:00 amRNSNotice of Investor Presentation
24th Jul 20237:00 amRNSTrading Update
5th Jul 20234:52 pmRNSTransaction in Own Shares and Total Voting Rights
4th Jul 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Jun 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Jun 20237:00 amRNSTrading Update
14th Jun 20233:46 pmRNSTransaction in Own Shares and Total Voting Rights
12th Jun 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
18th May 20233:10 pmRNSResult of AGM
17th May 20236:10 pmRNSTransaction in Own Shares and Total Voting Rights
17th May 20237:00 amRNSAGM Statement
12th May 20232:26 pmRNSTransaction in Own Shares and Total Voting Rights
4th May 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Apr 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Apr 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Apr 20236:15 pmRNSUpdate re: RSUs & Director/PDMR Shareholding
26th Apr 20237:00 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.